Mylan NV (NASDAQ:MYL) is a leading developer of branded and generic drugs. The stock has been slumping since peaking in late January 2018 at $46.72 a share. Since that high pivot, the stock has fallen by more than 10.0 points and is now trading at $36.33 a share. The current daily chart pattern is forming a bearish consolidation pattern which indicates lower share prices ahead. Traders and investors should now watch for major support around the $34.50 area. This support level is where MYL broke out in October 2017 and should be defended again when retested.